PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PI3K isoform-selective inhibitors: next-generation targeted cancer therapies have?
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies has 124 citations in the OpenAlex counts ScholarIQ stores.
When was PI3K isoform-selective inhibitors: next-generation targeted cancer therapies published?
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies has 2015 year in the ScholarIQ index.
What is the open-access status of PI3K isoform-selective inhibitors: next-generation targeted cancer therapies?
PI3K isoform-selective inhibitors: next-generation targeted cancer therapies has bronze oa status in the ScholarIQ index.
What is the DOI of PI3K isoform-selective inhibitors: next-generation targeted cancer therapies?
The DOI for PI3K isoform-selective inhibitors: next-generation targeted cancer therapies is on the source record.
What is the PMID of PI3K isoform-selective inhibitors: next-generation targeted cancer therapies?
The PMID for PI3K isoform-selective inhibitors: next-generation targeted cancer therapies is on the source record.
What is the OpenAlex record for PI3K isoform-selective inhibitors: next-generation targeted cancer therapies?
The OpenAlex for PI3K isoform-selective inhibitors: next-generation targeted cancer therapies is on the source record.